Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01517776
Brief Title: Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents (HGG-CilMetro)

First Submitted : January 11, 2012
First Submitted that Met QC Criteria : January 20, 2012
First Posted : January 25, 2012 (Estimate)

Certification/Extension First Submitted : May 26, 2015
Certification/Extension First Submitted that Met QC Criteria : June 26, 2015
Certification/Extension First Posted : July 21, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 26, 2015
Last Update Posted : July 21, 2015 (Estimate)